GLUT2 protein at the rat proximal tubule brush border membrane correlates with protein kinase C (PKC)-betal and plasma glucose concentration

Diabetologia. 2007 Oct;50(10):2209-17. doi: 10.1007/s00125-007-0778-x. Epub 2007 Aug 11.

Abstract

Aims/hypothesis: GLUT2 is the main renal glucose transporter upregulated by hyperglycaemia, when it becomes detectable at the brush border membrane (BBM). Since glucose-induced protein kinase C (PKC) activation in the kidney is linked to diabetic nephropathy, we investigated the effect of glycaemic status on the protein levels of PKC isoforms alpha, betaI, betaII, delta and epsilon in the proximal tubule, as well as the relationship between them and changes in GLUT2 production at the BBM.

Methods: Plasma glucose concentrations were modulated in rats by treatment with nicotinamide 15 min prior to induction of diabetes with streptozotocin. Levels of GLUT2 protein and PKC isoforms in BBM were measured by western blotting. Additionally, the role of calcium signalling and PKC activation on facilitative glucose transport was examined by measuring glucose uptake in BBM vesicles prepared from proximal tubules that had been incubated either with thapsigargin, which increases cytosolic calcium, or with the PKC activator phorbol 12-myristate,13-acetate (PMA).

Results: Thapsigargin and PMA enhanced GLUT-mediated glucose uptake, but had no effect on sodium-dependent glucose transport. Diabetes significantly increased the protein levels of GLUT2 and PKC-betaI at the BBM. Levels of GLUT2 and PKC-betaI correlated positively with plasma glucose concentration. Diabetes had no effect on BBM levels of alpha, betaII, delta or epsilon isoforms of PKC.

Conclusions/interpretation: Enhanced GLUT2-mediated glucose transport across the proximal tubule BBM during diabetic hyperglycaemia is closely associated with increased PKC-betaI. Thus, altered levels of GLUT2 and PKC-betaI proteins in the BBM may be important factors in the pathogenic processes underlying diabetic renal injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / enzymology
  • Diabetes Mellitus, Experimental / metabolism*
  • Enzyme Activation
  • Glucose Transporter Type 2 / drug effects
  • Glucose Transporter Type 2 / metabolism*
  • Kidney / anatomy & histology
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism*
  • Kidney Tubules, Proximal / physiology
  • Male
  • Microvilli / drug effects
  • Microvilli / metabolism*
  • Microvilli / physiology
  • Niacinamide / pharmacology
  • Organ Size
  • Protein Kinase C / drug effects
  • Protein Kinase C / metabolism*
  • Protein Kinase C beta
  • Rats
  • Rats, Sprague-Dawley
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thapsigargin / pharmacology
  • Weight Gain

Substances

  • Blood Glucose
  • Glucose Transporter Type 2
  • Slc2a2 protein, rat
  • Niacinamide
  • Thapsigargin
  • Protein Kinase C
  • Protein Kinase C beta
  • Tetradecanoylphorbol Acetate